Risk for exacerbation, hospitalization and mortality in Global Initiative for Chronic Obstructive Lung Disease group B patients with and without exacerbations: a cohort study
L. Vanfleteren (Gothenburg, Sweden), L. Holmstrand (Gothenburg, Sweden), A. Lindberg (Umeå, Sweden), C. Zhou (Gothenburg, Sweden), F. Nyberg (Gothenburg, Sweden), C. Stridsman (Gothenburg, Sweden)
Source: International Congress 2022 – COPD clinical studies and exacerbations
Session: COPD clinical studies and exacerbations
Session type: Thematic Poster
Number: 3614
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Vanfleteren (Gothenburg, Sweden), L. Holmstrand (Gothenburg, Sweden), A. Lindberg (Umeå, Sweden), C. Zhou (Gothenburg, Sweden), F. Nyberg (Gothenburg, Sweden), C. Stridsman (Gothenburg, Sweden). Risk for exacerbation, hospitalization and mortality in Global Initiative for Chronic Obstructive Lung Disease group B patients with and without exacerbations: a cohort study. 3614
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|